Detalles de la búsqueda
1.
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials.
Circulation
; 145(19): 1471-1479, 2022 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35389229
2.
Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study.
Am Heart J
; 235: 12-23, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33577800
3.
Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis.
Clin Appl Thromb Hemost
; 27: 10760296211053316, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34719984
4.
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients.
J Am Heart Assoc
; 10(5): e019459, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33586478
5.
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.
Clin Appl Thromb Hemost
; 25: 1076029619886022, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31746218
Resultados
1 -
5
de 5
1
Próxima >
>>